![Nathan Bryson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan Bryson
Directeur Technique/Scientifique/R&D chez
Reunion Neuroscience, Inc.
Profil
Nathan Bryson is the founder of Flamel Technologies SA, founded in 1990.
Dr. Bryson is currently Chief Scientific Officer at Reunion Neuroscience, Inc. since 2022.
Former positions include Chief Scientific Officer at Cynapsus Therapeutics, Inc. from 2009 to 2014, Vice President-Research at Bionisis SA in 2008, Vice President-Research & Development at Matregen Corp.
from 2005 to 2007, Chief Scientific Officer at Acerus Pharmaceuticals Corp.
from 2014 to 2020, and Chief Science Officer at Field Trip Health Ltd. from 2020 to 2022.
Education includes an undergraduate degree from Auburn University in 1984 and a doctorate from Massachusetts Institute of Technology in 1988.
Postes actifs de Nathan Bryson
| Sociétés | Poste | Début |
|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Directeur Technique/Scientifique/R&D | 01/08/2022 |
Anciens postes connus de Nathan Bryson
| Sociétés | Poste | Fin |
|---|---|---|
| REUNION NEUROSCIENCE | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| ACERUS PHARMACEUTICALS CORPORATION | Directeur Technique/Scientifique/R&D | 06/03/2020 |
| CYNAPSUS THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 22/01/2014 |
Bionisis SA
 Bionisis SA Medical SpecialtiesHealth Technology Supplies proprietary solutions for the separation, purification and analysis of chemical and biochemical mixtures | Directeur Technique/Scientifique/R&D | 02/12/2008 |
Matregen Corp.
 Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes drug delivery systems | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Formation de Nathan Bryson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Bionisis SA
Bionisis SA Medical SpecialtiesHealth Technology Supplies proprietary solutions for the separation, purification and analysis of chemical and biochemical mixtures | Health Technology |
Matregen Corp.
Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes drug delivery systems | Commercial Services |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Field Trip Health Ltd.
 Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Provides psychedelic-enhanced psychotherapy services | Health Services |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
